There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

Researchers in Edinburgh have made a significant breakthrough by studying living human brain tissue to understand how ...

Medications like donanemab (Kisunla) and lecanemab (Leqembi) target amyloid plaques that build up in the brain due to ...

HealthDay News — An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension ...

Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using ...

For the first time scientists have seen how a protein linked to Alzheimer’s sticks to brain cells and causes damage. | ITV ...